These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 38265001)
21. Use of MRI Radiomics Models in Evaluating the Low HER2 Expression in Breast Cancer. Li H; Hou Y; Xue LY; Fan WL; Gao BL; Yin XP Curr Med Imaging; 2024; 20():e15734056234429. PubMed ID: 38726785 [TBL] [Abstract][Full Text] [Related]
22. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions. Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014 [TBL] [Abstract][Full Text] [Related]
23. Clinical Breast MRI-based Radiomics for Distinguishing Benign and Malignant Lesions: An Analysis of Sequences and Enhanced Phases. Wang G; Guo Q; Shi D; Zhai H; Luo W; Zhang H; Ren Z; Yan G; Ren K J Magn Reson Imaging; 2024 Sep; 60(3):1178-1189. PubMed ID: 38006286 [TBL] [Abstract][Full Text] [Related]
24. Radiomics nomogram for differentiating between benign and malignant soft-tissue masses of the extremities. Wang H; Nie P; Wang Y; Xu W; Duan S; Chen H; Hao D; Liu J J Magn Reson Imaging; 2020 Jan; 51(1):155-163. PubMed ID: 31169956 [TBL] [Abstract][Full Text] [Related]
25. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study. Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729 [TBL] [Abstract][Full Text] [Related]
26. Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study. Zhou J; Yu X; Wu Q; Wu Y; Fu C; Wang Y; Hai M; Tan H; Wang M Heliyon; 2024 Apr; 10(7):e28722. PubMed ID: 38623231 [TBL] [Abstract][Full Text] [Related]
27. Nomogram Utilizing ABVS Radiomics and Clinical Factors for Predicting ≤ 3 Positive Axillary Lymph Nodes in HR+ /HER2- Breast Cancer with 1-2 Positive Sentinel Nodes. Hu B; Xu Y; Gong H; Tang L; Wang L; Li H Acad Radiol; 2024 Jul; 31(7):2684-2694. PubMed ID: 38383259 [TBL] [Abstract][Full Text] [Related]
28. Glioblastoma and Solitary Brain Metastasis: Differentiation by Integrating Demographic-MRI and Deep-Learning Radiomics Signatures. Zhang Y; Zhang H; Zhang H; Ouyang Y; Su R; Yang W; Huang B J Magn Reson Imaging; 2024 Sep; 60(3):909-920. PubMed ID: 37955154 [TBL] [Abstract][Full Text] [Related]
29. Noninvasive identification of HER2-zero, -low, or -overexpressing breast cancers: Multiparametric MRI-based quantitative characterization in predicting HER2-low status of breast cancer. Zhan T; Dai J; Li Y Eur J Radiol; 2024 Aug; 177():111573. PubMed ID: 38905803 [TBL] [Abstract][Full Text] [Related]
30. Prediction of histopathologic grades of bladder cancer with radiomics based on MRI: Comparison with traditional MRI. Li L; Zhang J; Zhe X; Tang M; Zhang L; Lei X; Zhang X Urol Oncol; 2024 Jun; 42(6):176.e9-176.e20. PubMed ID: 38556403 [TBL] [Abstract][Full Text] [Related]
31. Integrating intratumoral and peritumoral radiomics with deep transfer learning for DCE-MRI breast lesion differentiation: A multicenter study comparing performance with radiologists. Yu T; Yu R; Liu M; Wang X; Zhang J; Zheng Y; Lv F Eur J Radiol; 2024 Aug; 177():111556. PubMed ID: 38875748 [TBL] [Abstract][Full Text] [Related]
32. Multiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer. Xiao M; Ma F; Li Y; Li Y; Li M; Zhang G; Qiang J J Magn Reson Imaging; 2020 Sep; 52(3):885-896. PubMed ID: 32096586 [TBL] [Abstract][Full Text] [Related]
33. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps. Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388 [TBL] [Abstract][Full Text] [Related]
34. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study. Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187 [TBL] [Abstract][Full Text] [Related]
35. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer. Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845 [TBL] [Abstract][Full Text] [Related]
36. Performance of radiomics models for tumour-infiltrating lymphocyte (TIL) prediction in breast cancer: the role of the dynamic contrast-enhanced (DCE) MRI phase. Tang WJ; Kong QC; Cheng ZX; Liang YS; Jin Z; Chen LX; Hu WK; Liang YY; Wei XH; Guo Y; Jiang XQ Eur Radiol; 2022 Feb; 32(2):864-875. PubMed ID: 34430998 [TBL] [Abstract][Full Text] [Related]
37. Evaluating Tumor-Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI-Based Radiomics. Bian T; Wu Z; Lin Q; Mao Y; Wang H; Chen J; Chen Q; Fu G; Cui C; Su X J Magn Reson Imaging; 2022 Mar; 55(3):772-784. PubMed ID: 34453461 [TBL] [Abstract][Full Text] [Related]
38. Noninvasive identification of HER2-low-positive status by MRI-based deep learning radiomics predicts the disease-free survival of patients with breast cancer. Guo Y; Xie X; Tang W; Chen S; Wang M; Fan Y; Lin C; Hu W; Yang J; Xiang J; Jiang K; Wei X; Huang B; Jiang X Eur Radiol; 2024 Feb; 34(2):899-913. PubMed ID: 37597033 [TBL] [Abstract][Full Text] [Related]
39. Elaboration of Multiparametric MRI-Based Radiomics Signature for the Preoperative Quantitative Identification of the Histological Grade in Patients With Non-Small-Cell Lung Cancer. Tang X; Bai G; Wang H; Guo F; Yin H J Magn Reson Imaging; 2022 Aug; 56(2):579-589. PubMed ID: 35040525 [TBL] [Abstract][Full Text] [Related]
40. Value of radiomics based on CE-MRI for predicting the efficacy of neoadjuvant chemotherapy in invasive breast cancer. Li Q; Huang Y; Xiao Q; Duan S; Wang S; Li J; Niu Q; Gu Y Br J Radiol; 2022 Oct; 95(1139):20220186. PubMed ID: 36005646 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]